Failure to Monitor INR and Administer Coumadin
Summary
The facility failed to complete INR monitoring tests to ensure therapeutic dosing of Coumadin for a resident with a history of atrial fibrillation, coronary artery disease, cerebrovascular accident, seizure disorder, and a heart valve replacement. The resident was taking an anticoagulant to prevent blood clots, which required regular PT/INR testing to monitor the effectiveness of the medication. However, the facility did not consistently perform these tests or follow up with the prescriber for Coumadin orders, leading to missed doses and a significant medication error. The record review revealed multiple instances where PT/INR tests were either not completed or not communicated to the prescriber in a timely manner. For example, on several occasions, the PT/INR was completed, but the results were not called to the prescriber until days later, resulting in a lapse in Coumadin therapy. Additionally, there were no orders for Coumadin dosing on certain days, and the facility failed to obtain new orders promptly, further contributing to the medication error. Interviews with the Director of Nursing confirmed that the missed doses of Coumadin were a significant medication error and that nursing staff should have called the prescriber with PT/INR results on the day the tests were taken. The facility's policy on medication errors and adverse reactions emphasized the importance of administering medications in accordance with prescriber's orders, which was not adhered to in this case.
Removal Plan
- The DNS or designee will identify all other residents on routine narcotics to complete full audit of eMAR documented administration and verification of medication availability.
- The DNS or designee will educate nurses and CMAs currently working and all other licensed staff prior to working their next shift. Electronic education will be completed with all nurses and CMAs. Education will include expected use and instructions on use of facility emergency medication kit, correct ordering of medication and clear expectation on time and expectation to complete physician ordered PT/INR blood draw, as well as expectation of time deadlines to notify PCP or coumadin clinic, manually entering telephone orders for next INR and coumadin dose.
- The DNS or designated clinical manager will complete all INR draws and notification, while completing follow up education and verification of understanding with nurses.
- The ED or designee will audit staff education completion of the above areas every shift. The DNS or designee will audit eMAR for omissions of missed narcotic prior to end of shift or until substantial compliance is determined. The DNS or designee will audit eMAR and progress notes for omissions of INR completion and PCP notification or until substantial compliance is determined. The above audits will submitted to QAPI monthly until substantial compliance is determined.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.